The accumulation of insoluble TDP-43 is also observable post-mortem in other neurological and systematic pathologies including in 19–57% of Alzheimer’s disease patients [25], 85% of cases of chronic traumatic encephalopathy [26] and in Lewy body-related dementias [27]. This evidence concerns the gene TARDBP and Alzheimer disease.